From: The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis
Outcomes | Publication biasa | Heterogeneity (I-squared%) | Pooled prevalence (95%CI) |
---|---|---|---|
Hypothyroidism | 0.167 | 78% | 0.03 (0.02, 0.05) |
Isolated elevated FT4 | 0.173 | 66% | 0.02 (0.00, 0.04) |
Isolated low FT4 | 0.173 | 0% | 0.01 (0.00, 0.01) |
NTIS | 0.065 | 98% | 0.26 (0.10, 0.42) |
Thyrotoxicosis | 0.143 | 89% | 0.10 (0.04, 0.16) |